Identification of missed viruses by metagenomic sequencing of clinical respiratory samples from Kenya.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 01 2022
Historique:
received: 03 06 2021
accepted: 02 12 2021
entrez: 8 1 2022
pubmed: 9 1 2022
medline: 24 2 2022
Statut: epublish

Résumé

Pneumonia remains a major cause of mortality and morbidity. Most molecular diagnoses of viruses rely on polymerase chain reaction (PCR) assays that however can fail due to primer mismatch. We investigated the performance of routine virus diagnostics in Kilifi, Kenya, using random-primed viral next generation sequencing (viral NGS) on respiratory samples which tested negative for the common viral respiratory pathogens by a local standard diagnostic panel. Among 95 hospitalised pneumonia patients and 95 household-cohort individuals, analysis of viral NGS identified at least one respiratory-associated virus in 35 (37%) and 23 (24%) samples, respectively. The majority (66%; 42/64) belonged to the Picornaviridae family. The NGS data analysis identified a number of viruses that were missed by the diagnostic panel (rhinovirus, human metapneumovirus, respiratory syncytial virus and parainfluenza virus), and these failures could be attributed to PCR primer/probe binding site mismatches. Unexpected viruses identified included parvovirus B19, enterovirus D68, coxsackievirus A16 and A24 and rubella virus. The regular application of such viral NGS could help evaluate assay performance, identify molecular causes of missed diagnoses and reveal gaps in the respiratory virus set used for local screening assays. The results can provide actionable information to improve the local pneumonia diagnostics and reveal locally important viral pathogens.

Identifiants

pubmed: 34997042
doi: 10.1038/s41598-021-03987-1
pii: 10.1038/s41598-021-03987-1
pmc: PMC8742071
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

202

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102975
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 090853
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

BMC Infect Dis. 2016 Jun 17;16:301
pubmed: 27316548
Clin Infect Dis. 2012 Apr;54 Suppl 2:S190-9
pubmed: 22403235
mSphere. 2019 Jan 23;4(1):
pubmed: 30674646
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 04;368(1614):20120205
pubmed: 23382427
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
J Clin Virol. 2010 Jun;48(2):91-5
pubmed: 20413345
Sci Rep. 2020 Sep 21;10(1):15392
pubmed: 32958861
Intervirology. 2017;60(6):271-275
pubmed: 29898445
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Infect Dis. 2009 Nov 1;49(9):1341-9
pubmed: 19788358
J Clin Virol. 2017 Mar;88:21-25
pubmed: 28107671
PLoS One. 2018 Aug 16;13(8):e0202054
pubmed: 30114205
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
J Med Virol. 2012 May;84(5):823-31
pubmed: 22431032
J Infect Dis. 2019 Mar 15;219(7):1049-1057
pubmed: 30576538
J Infect Dis. 2014 Jun 1;209(11):1685-92
pubmed: 24367040
Clin Infect Dis. 2018 Oct 30;67(10):1559-1567
pubmed: 29668861
Virus Evol. 2017 Mar 05;3(Suppl 1):
pubmed: 28845270
Wellcome Open Res. 2018 Jul 25;3:89
pubmed: 30175247
J Clin Virol. 2005 Aug;33(4):341-4
pubmed: 15927526
Virus Evol. 2016 Oct 03;2(2):vew027
pubmed: 28748110
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
Virus Evol. 2018 Jul 13;4(2):vey020
pubmed: 30026965
JAMA. 2010 May 26;303(20):2051-7
pubmed: 20501927

Auteurs

My V T Phan (MVT)

Virus Genomics, Wellcome Trust Sanger Institute, Hinxton, UK. my.phan@lshtm.ac.uk.
MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda. my.phan@lshtm.ac.uk.

Charles N Agoti (CN)

Epidemiology and Demography Department, KEMRI -Wellcome Trust Research Programme, Kilifi, Kenya.
School of Health and Human Sciences, Pwani University, Kilifi, Kenya.

Patrick K Munywoki (PK)

Epidemiology and Demography Department, KEMRI -Wellcome Trust Research Programme, Kilifi, Kenya.
School of Health and Human Sciences, Pwani University, Kilifi, Kenya.

Grieven P Otieno (GP)

Epidemiology and Demography Department, KEMRI -Wellcome Trust Research Programme, Kilifi, Kenya.

Mwanajuma Ngama (M)

Epidemiology and Demography Department, KEMRI -Wellcome Trust Research Programme, Kilifi, Kenya.

Paul Kellam (P)

Virus Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.
Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.

Matthew Cotten (M)

Virus Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.
MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.
MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.

D James Nokes (DJ)

Epidemiology and Demography Department, KEMRI -Wellcome Trust Research Programme, Kilifi, Kenya. JNokes@kemri-wellcome.org.
School of Life Sciences and Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Coventry, UK. JNokes@kemri-wellcome.org.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH